RXST vs STAA: stock comparison and AI forecast
Rxsight, Inc. (RXST) and Staar Surgical Co (STAA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RXST Rxsight, Inc.
- Market Cap
- $189M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
STAA Staar Surgical Co
- Market Cap
- $1.26B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- STAA is 6.7 times larger than RXST by market capitalization ($1.26B against $189M).
- STAA turns 0.2% of its revenue into net income, against -43.8% for RXST.
- RXST carries 0.34 times debt per unit of equity, against 0.29 times for STAA.
- Both companies share the SEC industry classification Ophthalmic Goods.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RXST | STAA |
|---|---|---|
| Market Cap | $189M | $1.26B |
| P/B Ratio | 0.74x | 3.36x |
| EPS | $-1.10 | $-0.25 |
| Book Value/Share | $6.13 | $7.50 |
| Revenue/Share | $2.93 | $6.55 |
| FCF/Share | $0.45 | $0.36 |
Profitability & Margins
| Metric | RXST | STAA |
|---|---|---|
| ROE | -20.9% | 0.1% |
| ROA | -15.7% | 0.1% |
| ROIC | -23.1% | 0.2% |
| Gross Margin | 76.1% | 73.6% |
| Operating Margin | -50.4% | 0.2% |
| Net Margin | -43.8% | 0.2% |
| EBT Margin | -43.7% | 1.7% |
| Tax Rate | -0.2% | 90.5% |
Financial Health
| Metric | RXST | STAA |
|---|---|---|
| Current Ratio | 4.20x | 4.68x |
| Quick Ratio | 3.67x | 4.29x |
| D/E Ratio | 0.34x | 0.29x |
| Financial Leverage | 1.34x | 1.29x |
| Interest Coverage | -6172.7x | – |
| Working Capital | $240M | $278M |
Cash Flow
| Metric | RXST | STAA |
|---|---|---|
| Operating Cash Flow | $24M | $21M |
| Free Cash Flow | $19M | $18M |
| Capital Spending | -$5M | -$4M |
| FCF/Sales | 15.3% | 5.4% |
| CapEx/Sales | 4.1% | 1.1% |
Operational Efficiency
| Metric | RXST | STAA |
|---|---|---|
| Asset Turnover | 0.36x | 0.68x |
| Receivables Turnover | 7.2x | 3.8x |
| Inventory Turnover | 0.7x | 2.9x |
| Fixed Assets Turnover | 8.3x | 4.8x |
| Days Sales Outstanding | 51 days | 96 days |
| Days Inventory | 497 days | 124 days |
| Payables Period | 43 days | 60 days |
| Cash Conversion Cycle | 505 days | 161 days |
Income Statement
| Metric | RXST | STAA |
|---|---|---|
| Total Revenue | $122M | $328M |
| Operating Income | -$61M | $700K |
| Net Income | -$53M | $530K |
| R&D Expense | $37M | $37M |
| SG&A Expense | $117M | $241M |
| Cost of Goods Sold | $29M | $87M |
Dividend & Shareholder Information
| Metric | RXST | STAA |
|---|---|---|
| Shares Outstanding | 42M | 50M |
RXST vs STAA: stock comparison and AI forecast
Which is bigger, RXST or STAA?
STAA is 6.7 times larger than RXST by market capitalization ($1.26B against $189M).
Which one does Intratio's AI model rank higher, RXST or STAA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.